Scientific Board

Sarcoma Patients EuroNet established a Scientific Board with a high level of scientific expertise with the following objectives:

Support SPAEN in:

  • gaining legitimacy within the European and International community of experts involved in Sarcoma, GIST and desmoïd tumours;
  • ensuring patient representation and integration in major scientific committees and groups of experts at a national and international level.

Appointed members of the SPAEN Scientific Board:     

Name Field Country/City  Expert Group
 Prof. Jean Yves Blay (Chair)  Oncology  France/Lyon  GSF GETO
 Prof. Javier Martin Broto  Oncology  Spain/Sevilla  GEIS
 Dr. Paolo Casali  Oncology  Italy/Milano  ISG
 Prof. Jean Michel Coindre  Pathology  France/Bordeaux  GSF GETO
 Prof. Mikael Eriksson  Oncology  Sweden/Lund  SSG
 Dr. Alessandro Gronchi  Surgery  Italy/Milano  ISG
 Prof. Peter Hohenberger  Surgery  Germany/Mannheim  GISG/KO.SAR
 Mr. Craig Gerrand  Surgery  UK/Newcastle  BSG
 PD Dr. Peter Reichardt  Oncology  Germany/Berlin  GISG
 Prof. Piotr Rutkowski  Surgery  Poland/Warsaw  POLSG
 Dr. Beatrice Seddon  Oncology  UK/London  BSG
 Prof. Winette van der Graaf  Oncology Netherlands/Amsterdam  EORTC STBSG
 Dr. Rick Haas  Radiotherapy  Netherlands/Amsterdam  EORTC STBSG
 Prof. Bernd Kasper  Oncology  Germany/Mannheim  EORTC STBSG
 Dr. Robin Jones  Oncology  London/UK  BSG


“Sarcoma Patients EuroNet is a very welcome development. We need to involve patients in clinical trials at the design stage so that the relevance of what we do can be considered at the outset. In addition, SPAEN will be valuable helping patients understand what being tr eated in a clinical trial could mean to them. Together we can complete research more quickly and introduce new treatments faster.”

Prof. Dr. Jean Yes Blay, Chair of the SPAEN Scientific Board